{"id":"https://openalex.org/W1995413374","doi":"https://doi.org/10.1248/bpb.18.1382","title":"Inhibitory Effect of Isoliquiritin, a Compound in Licorice Root, on Angiogenesis in Vivo and Tube Formation in Vitro.","display_name":"Inhibitory Effect of Isoliquiritin, a Compound in Licorice Root, on Angiogenesis in Vivo and Tube Formation in Vitro.","alternate_titles":[],"publication_year":1995,"publication_date":"1995-10-01","ids":{"openalex":"https://openalex.org/W1995413374","doi":"https://doi.org/10.1248/bpb.18.1382","mag":"1995413374","pmid":"https://pubmed.ncbi.nlm.nih.gov/8593441"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.18.1382","doi":"https://doi.org/10.1248/bpb.18.1382","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.18.1382","pdf_url":"https://www.jstage.jst.go.jp/article/bpb1993/18/10/18_10_1382/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995413374"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/bpb1993/18/10/18_10_1382/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101491894","display_name":"Shinjiro Kobayashi","orcid":"https://orcid.org/0000-0002-5813-4867","observed_orcids":["https://orcid.org/0000-0002-5813-4867"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shinjiro KOBAYASHI","raw_affiliation_strings":["Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112158134","display_name":"Takayuki Miyamoto","orcid":"https://orcid.org/0009-0004-8036-6420","observed_orcids":["https://orcid.org/0009-0004-8036-6420"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takayuki MIYAMOTO","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055757122","display_name":"Ikuko Kimura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ikuko KIMURA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111921599","display_name":"Masayasu KIMURA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masayasu KIMURA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4492,"has_fulltext":false,"cited_by_count":110,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.76871102,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"18","issue":"10","first_page":"1382","last_page":"1386"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12817","display_name":"Pharmacological Effects of Natural Compounds","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12817","display_name":"Pharmacological Effects of Natural Compounds","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11709","display_name":"Traditional Chinese Medicine Analysis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isoliquiritin","display_name":"isoliquiritin","score":1.0},{"id":"https://openalex.org/keywords/licorice-root","display_name":"licorice root","score":0.9769999980926514},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/endothelial-tube-formation","display_name":"endothelial tube formation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/flavonoids","display_name":"flavonoids","score":0.8119999766349792},{"id":"https://openalex.org/keywords/glycyrrhizin","display_name":"glycyrrhizin","score":0.9010000228881836},{"id":"https://openalex.org/keywords/saponins","display_name":"saponins","score":0.8759999871253967},{"id":"https://openalex.org/keywords/isoliquiritigenin","display_name":"isoliquiritigenin","score":0.8640000224113464},{"id":"https://openalex.org/keywords/liquiritigenin","display_name":"liquiritigenin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/glycyrrhetinic-acid","display_name":"glycyrrhetinic acid","score":0.8539999723434448},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8090000152587891}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7465335130691528},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.7170664072036743},{"id":"https://openalex.org/C2778993495","wikidata":"https://www.wikidata.org/wiki/Q157830","display_name":"Glycyrrhiza","level":3,"score":0.5911840200424194},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.546983003616333},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5284507274627686},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4825953245162964},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.442132830619812},{"id":"https://openalex.org/C2777551473","wikidata":"https://www.wikidata.org/wiki/Q2093072","display_name":"Tube (container)","level":2,"score":0.4196302890777588},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2438829243183136},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22750705480575562},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.1760776937007904},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15706437826156616},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.10331413149833679},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07497036457061768},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.06557521224021912},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.06487354636192322},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002599","descriptor_name":"Chalcone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002599","descriptor_name":"Chalcone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006034","descriptor_name":"Glycyrrhetinic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006034","descriptor_name":"Glycyrrhetinic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006035","descriptor_name":"Glycyrrhiza","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006099","descriptor_name":"Granuloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008870","descriptor_name":"Microtubules","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010936","descriptor_name":"Plant Extracts","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010946","descriptor_name":"Plants, Medicinal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019695","descriptor_name":"Glycyrrhizic Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.18.1382","doi":"https://doi.org/10.1248/bpb.18.1382","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.18.1382","pdf_url":"https://www.jstage.jst.go.jp/article/bpb1993/18/10/18_10_1382/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:8593441","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8593441","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.18.1382","doi":"https://doi.org/10.1248/bpb.18.1382","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.18.1382","pdf_url":"https://www.jstage.jst.go.jp/article/bpb1993/18/10/18_10_1382/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1995413374.pdf","grobid_xml":"https://content.openalex.org/works/W1995413374.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1973005957","https://openalex.org/W1986535866","https://openalex.org/W2029063291","https://openalex.org/W2033655377","https://openalex.org/W2056626174","https://openalex.org/W2062456857","https://openalex.org/W2066123070","https://openalex.org/W2074006215","https://openalex.org/W2079760972","https://openalex.org/W2095033800","https://openalex.org/W2095548353","https://openalex.org/W2269232142","https://openalex.org/W2321330457","https://openalex.org/W4246719372","https://openalex.org/W4255042798"],"related_works":["https://openalex.org/W2115117807","https://openalex.org/W2257832253","https://openalex.org/W2233519313","https://openalex.org/W2000163456","https://openalex.org/W2379585448","https://openalex.org/W840428222","https://openalex.org/W2136613853","https://openalex.org/W2092208413","https://openalex.org/W2315559133","https://openalex.org/W2286063246"],"abstract_inverted_index":{"A":[0,116],"water":[1],"extract":[2,64,169],"of":[3,25,41,83,131,134,158,167,176],"licorice":[4,47,63,152,168],"root":[5],"inhibits":[6],"granuloma":[7,29,42],"angiogenesis":[8],"in":[9,75,95,121,150],"adjuvant-induced":[10],"chronic":[11],"inflammation":[12],"(Phytother.":[13],"Res.,":[14],"5,":[15],"195.":[16],"1991).":[17],"The":[18,62,128],"present":[19],"study":[20],"has":[21],"investigated":[22],"the":[23,38,80,96,151,156,164,172],"effects":[24],"licorice-derived":[26,35,53,85],"compounds":[27],"on":[28,171],"angiogenesis.":[30],"Isoliquiritin":[31],"(0.31-3.1":[32],"mg/kg),":[33,51],"a":[34,52,59,76,132,142],"flavonoid,":[36],"inhibited":[37,55,68,125],"carmine":[39,56],"content":[40,57],"tissue":[43],"50-fold":[44],"greater":[45],"than":[46],"extract.":[48,161],"Glyeyrrhizin":[49],"(20-80":[50],"saponin,":[54],"with":[58],"weak":[60],"potency.":[61],"(0.01-1":[65],"mg/ml)":[66],"also":[67],"tube":[69,114,122],"formation":[70,93,123,174],"from":[71],"vascular":[72],"endothelial":[73],"cells":[74],"concentration-dependent":[77],"manner.":[78],"From":[79],"chemical":[81],"structure-activities":[82],"used":[84],"flavonoids":[86],"(0.1-100":[87,106],"microM),":[88],"their":[89,147],"potencies":[90],"for":[91],"anti-tube":[92,173],"were":[94],"order":[97],"isoliquiritigenin":[98],">":[99,101],"isoliquiritin":[100],"liquiritigenin":[102],">>":[103],"isoliquiritin-apioside.":[104],"Glycyrrhizin":[105],"microM)":[107,112],"and":[108,138],"glycyrrhetinic":[109],"acid":[110],"(0.1-10":[111],"increased":[113],"formation.":[115],"glycyrrhizin":[117,137],"(82":[118],"micrograms/ml)-induced":[119],"increase":[120],"was":[124],"by":[126],"isoliquiritin.":[127,177],"combined":[129],"effect":[130,157,166,175],"mixture":[133],"82":[135],"micrograms/ml":[136,140,160],"4.2":[139],"isoliquiritin,":[141],"similar":[143],"concentration":[144],"ratio":[145,149],"to":[146,155],"yield":[148],"extract,":[153],"corresponded":[154],"100":[159],"In":[162],"conclusion,":[163],"anti-angiogenic":[165],"depended":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995413374","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
